Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.00091 | 1 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.00038 | 1 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |